Anil Gaikwad-Bhanudas
Pilani, RJ 333031, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Targeting the lncRNA PVT-1-Hippo signaling axis in kidney diseases: an emerging therapeutic paradigm.
Journal: Molecular biology reports
Published: July 03, 2026
Exogenous klotho as an adjunct to dapagliflozin ameliorates diabetic kidney disease by restoring mitophagy and mitigating apoptosis and fibrosis.
Journal: Biochemical and biophysical research communications
Published: May 07, 2026
Citropten from Citrus sinensis peel protects against obstructive chronic kidney disease: insights from network pharmacology and experimental validation.
Journal: Food & function
Published: March 02, 2026
The role of protein prenylation in kidney diseases: Molecular basis and therapeutic implications.
Journal: Molecular biology reports
Published: December 29, 2025
Deciphering the role of mitochondrial cytochrome C oxidase subunit 4 in cardiac health and disease.
Journal: Life sciences
Published: December 23, 2025
Targeting TLR4 with ligustrazine and AT1R with telmisartan ameliorates diabetic kidney disease.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: December 15, 2025
Piezo1 as a therapeutic target in kidney disease: emerging mechanistic insights and translational potential.
Journal: Drug discovery today
Published: November 04, 2025
Bridging gut microbiota and renal health: Klotho as a promising therapeutic agent in DKD.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: October 22, 2025
Targeting LncRNAs with CRISPR/Cas9 for Kidney Therapeutics: A Review.
Journal: International journal of biological macromolecules
Published: October 19, 2025
Guaiacol counters renal fibrosis via BMP/ERK/Smad1/5/9 signaling in UUO-induced chronic kidney disease.
Journal: The Journal of nutritional biochemistry
Published: October 17, 2025
Risedronate attenuates renal fibrosis by targeting prenylation-dependent RhoA/ROCK1 and ERK/NF-κB signaling.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: September 20, 2025
Diabetic kidney disease: exploring mechanistic depths and the future of pharmacological intervention.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 22, 2025
Last Updated: 09/26/2026